HK biotech firm develops urine-based HPV test for cervical cancer screening

Phase Scientific, a Hong Kong biotech firm, is developing a urine-based HPV test using its sample-concentration technology to make cervical cancer screening more accessible. The company, known for its Covid-19 rapid antigen test, is pursuing a breakthrough in non-invasive diagnostics. The development is at an early stage, with regulatory and clinical validation still pending.